CSE: SONA | OTCQB: SNANF
   +1-902-442-0653   Purdy’s Wharf Tower II Suite 2001 – 1969 Upper Water Street
Sona Nanotech Sona Nanotech Sona Nanotech Sona Nanotech
  • Home
  • Science
    • Technology Overview
    • Targeted Hyperthermia Therapy
    • Scientific Evidence
  • Pipeline
  • Investors
    • Share Information
    • Investor Presentation
    • Research Coverage
    • Financial Reports
  • News & Media
    • News Releases
    • Carman’s Corner
    • Media Centre
    • Insights
  • About
    • Our Story
    • Leadership
    • Board of Directors
    • Advisory Board
Subscribe

CanAm Melanoma Treatment Efficacy Study Discussion

July 11, 2024
Webinars
Back to All Webinars

Latest

Media & Interviews

Revolutionary Cancer Therapy: Sona Nanotech’s Gold Nanorods Shrink Tumors from the Inside Out

Media & Interviews

Meet Kulbir Singh PhD – Sona’s co-founder & Head of R&D

Media & Interviews

GNR Based Diagnostics – The Making of Lateral Flow Devices

Subscribe to Our Newsletter
Download the Company Presentation
Download
Read in Frontiers in Immunology our Published Research

Targeted intra-tumoral hyperthermia using uniquely biocompatible gold nanorods induces strong immunogenic cell death in two immunogenically ‘cold’ tumor models.

Learn more
Sona Nanotech Logo png mobile

A clinical-stage oncology company advancing Targeted Hyperthermia Therapy for solid tumors, powered by uniquely biocompatible, CTAB-free gold nanorods.

Linkedin-in X-twitter Youtube
Science
  • Technology Overview
  • Targeted Hyperthermia Therapy
  • Scientific Evidence
  • Publications
  • Pipeline
  • Partnering
Investors
  • Share Information
  • Financial Reports
  • Investor Presentations
  • Research Coverage
News & Media
  • News Releases
  • Carman's Corner
  • Media Centre
  • Insights
About Us
  • Our Story
  • Leadership
  • Board of Directors
  • Advisory Board
  • Contact Us
Store
  • Order
  • Your Account
  • Shipping Information
© 2026 Sona Nanotech Inc. All rights reserved.
CSE: SONA · OTCQB: SNANF
Privacy Policy
Social Media Policy
Sona Nanotech
  • Home
  • Science
    • Technology Overview
    • Targeted Hyperthermia Therapy
    • Scientific Evidence
  • Pipeline
  • Investors
    • Share Information
    • Investor Presentation
    • Research Coverage
    • Financial Reports
  • News & Media
    • News Releases
    • Carman’s Corner
    • Media Centre
    • Insights
  • About
    • Our Story
    • Leadership
    • Board of Directors
    • Advisory Board
Subscribe